Texas 2015 84th Regular

Texas Senate Bill SB1560 House Committee Report / Bill

Filed 02/02/2025

Download
.pdf .doc .html
                    84R29620 LEH-D
 By: Zaffirini S.B. No. 1560
 (Lozano)
 Substitute the following for S.B. No. 1560:  No.


 A BILL TO BE ENTITLED
 AN ACT
 relating to the regulation of chemical dependency treatment
 facilities and certain other facilities.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 164.009(e), Health and Safety Code, is
 amended to read as follows:
 (e)  A chemical dependency facility may not represent or
 recommend that a prospective patient should be admitted to a
 facility for treatment unless and until:
 (1)  the prospective patient has been evaluated, in
 person, by a mental health professional; and
 (2)  a [the] mental health professional determines that
 the patient meets the facility's admission standards.
 SECTION 2.  Section 462.009, Health and Safety Code, is
 amended by adding Subsection (h) to read as follows:
 (h)  This section does not apply to a treatment facility
 licensed by the department under Chapter 464.
 SECTION 3.  Subchapter A, Chapter 462, Health and Safety
 Code, is amended by adding Sections 462.010, 462.011, 462.012,
 462.013, and 462.014 to read as follows:
 Sec. 462.010.  CONSENT TO TREATMENT AT CERTAIN FACILITIES.
 (a)  A treatment facility licensed by the department under Chapter
 464 may not provide treatment to a patient without the patient's
 legally adequate consent.
 (b)  The executive commissioner by rule shall prescribe
 standards for obtaining a patient's legally adequate consent under
 this section, including rules prescribing reasonable efforts to
 obtain a patient's consent and requiring documentation for those
 efforts.
 Sec. 462.011.  CONSENT TO MEDICATION. Consent to the
 administration of prescription medication given by a patient
 receiving treatment in a treatment facility licensed by the
 department under Chapter 464 or by a person authorized by law to
 consent on behalf of the patient is valid only if:
 (1)  the consent is given voluntarily and without
 coercive or undue influence;
 (2)  the patient and, if appropriate, the patient's
 representative authorized by law to consent on behalf of the
 patient are informed in writing that consent may be revoked; and
 (3)  the consent is evidenced in the patient's clinical
 record by a signed form prescribed by the treatment facility or by a
 statement of the treating physician or a person designated by the
 physician that documents that consent was given by the appropriate
 person and the circumstances under which the consent was obtained.
 Sec. 462.012.  RIGHT TO REFUSE MEDICATION. (a) Each patient
 receiving treatment in a treatment facility licensed by the
 department under Chapter 464 has the right to refuse unnecessary or
 excessive medication.
 (b)  Medication may not be used by the treatment facility:
 (1)  as punishment; or
 (2)  for the convenience of the staff.
 Sec. 462.013.  MEDICATION INFORMATION. (a) The executive
 commissioner by rule shall require the treating physician of a
 patient admitted to a treatment facility licensed by the department
 under Chapter 464 or a person designated by the physician to provide
 to the patient in the patient's primary language, if possible,
 information relating to prescription medications ordered by the
 physician.
 (b)  At a minimum, the required information must:
 (1)  identify the major types of prescription
 medications; and
 (2)  specify for each major type:
 (A)  the conditions the medications are commonly
 used to treat;
 (B)  the beneficial effects on those conditions
 generally expected from the medications;
 (C)  side effects and risks associated with the
 medications;
 (D)  commonly used examples of medications of the
 major type; and
 (E)  sources of detailed information concerning a
 particular medication.
 (c)  If the treating physician designates another person to
 provide the information under Subsection (a), then, not later than
 two working days after that person provides the information,
 excluding weekends and legal holidays, the physician shall meet
 with the patient and, if appropriate, the patient's representative
 who provided consent for the administration of the medications
 under Section 462.011, to review the information and answer any
 questions.
 (d)  The treating physician or the person designated by the
 physician shall also provide the information to the patient's
 family on request, but only to the extent not otherwise prohibited
 by state or federal confidentiality laws.
 Sec. 462.014.  LIST OF MEDICATIONS. (a) On the request of a
 patient, a person designated by the patient, or the patient's legal
 guardian or managing conservator, if any, the facility
 administrator of a treatment facility licensed by the department
 under Chapter 464 shall provide to the patient, the person
 designated by the patient, and the patient's legal guardian or
 managing conservator, a list of the medications prescribed for
 administration to the patient while the patient is in the treatment
 facility. The list must include for each medication:
 (1)  the name of the medication;
 (2)  the dosage and schedule prescribed for the
 administration of the medication; and
 (3)  the name of the physician who prescribed the
 medication.
 (b)  The list must be provided before the expiration of four
 hours after the facility administrator receives a written request
 for the list from the patient, a person designated by the patient,
 or the patient's legal guardian or managing conservator, if any. If
 sufficient time to prepare the list before discharge is not
 available, the list may be mailed before the expiration of 24 hours
 after discharge to the patient, the person designated by the
 patient, and the patient's legal guardian or managing conservator.
 (c)  A patient or the patient's legal guardian or managing
 conservator, if any, may waive the right of any person to receive
 the list of medications while the patient is participating in a
 research project if release of the list would jeopardize the
 results of the project.
 SECTION 4.  Section 462.025(h)(4), Health and Safety Code,
 is amended to read as follows:
 (4)  "Screening" means the process a treatment facility
 uses to determine whether a prospective patient presents sufficient
 signs, symptoms, or behaviors to warrant a more in-depth assessment
 by a qualified professional after the patient is admitted.
 SECTION 5.  Section 462.025(h)(2), Health and Safety Code,
 is repealed.
 SECTION 6.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2015.